NCT02514486View on ClinicalTrials.gov

Assessment of Cancer Concerns at the End of Treatment (ACE)

CompletedOBSERVATIONAL
Enrollment

332

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 19, 2018

Study Completion Date

January 19, 2018

Conditions
Breast Cancer(BC) Survivors
Interventions
BEHAVIORAL

Questionnaire

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02514486 - Assessment of Cancer Concerns at the End of Treatment (ACE) | Biotech Hunter | Biotech Hunter